Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2022-02-02 00:00:00 ET · period of report 2022-01-31 · accession 0001209191-22-006372 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-02 | 2022-01-31 | TVTX | Calvin Sandra | VP, CAO, Corp Ctrl | A - Grant | $0.00 | +8,750 | 37.4K | +31% | $0 |
| D | 2022-02-02 | 2022-01-31 | TVTX | Calvin Sandra | VP, CAO, Corp Ctrl | S - Sale | $26.51 | -798 | 36.6K | -2% | -$21.2K |
| D | 2022-02-02 | 2022-01-31 | TVTX | Calvin Sandra | VP, CAO, Corp Ctrl | A - Grant | $0.00 | +17.5K | 17.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-31 | A | A | 8,750 | $0.00 | 37,412 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-31 | S | D | 798 | $26.51 | 36,614 | D | — | — | |
| 3 | Derivative | Employee stock option (right to buy) | 2022-01-31 | A | A | 17,500 | $0.00 | 17,500 | D | $27.50 · — to 2032-01-30 | 17,500 Common Stock | (F3) One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter. |